Canadian flagCanadian fulfilment · Free shipping $199+For laboratory research only
My account →Peptide Points →About Peptide Place →

Compound research profile

What Is Ipamorelin?

Published November 2, 2026 · Updated November 9, 2026

Editorial cover for What Is Ipamorelin?
Editorial illustration · read the original sources for evidence.

Ipamorelin is a synthetic peptide studied as a growth hormone secretagogue. In plain language, that means it can stimulate growth hormone release in experimental settings. Its research interest is associated with the ghrelin-receptor pathway, which differs from the growth hormone-releasing hormone pathway discussed for tesamorelin.

What question does ipamorelin research address?

The starting question is how a named compound influences growth hormone release under defined conditions. This is a mechanism-and-response question. It is separate from asking whether a material changes muscle mass, recovery, sleep or body composition in a particular population. Those outcomes need their own measurements and study design.

When searching for ipamorelin benefits, keep the outcome beside the claim. A hormone response is one type of finding; it is not a substitute for every other endpoint sometimes associated with the compound. This profile explains how to read the research, while the Ipamorelin product page supplies current catalogue information.

Two original studies to recognise

Raun and colleagues’ 1998 paper describes ipamorelin’s development and experimental growth hormone-releasing pharmacology. Its use of “selective” is tied to the measured responses and conditions in that work. It should not be expanded into an unrestricted claim that there can be no other effects in every setting.

A separate pharmacokinetic-pharmacodynamic study in human volunteers examines exposure and the growth hormone response. That kind of study answers a narrower question than a long-term trial with a body-composition or functional endpoint. Read the participants, observation period and outcome before deciding what the paper supports.

Term Plain-language meaning What to check
Secretagogue Stimulates secretion Which response was measured?
Pharmacokinetics How exposure changes with time Which material and study population?
Pharmacodynamics The response associated with exposure Is the endpoint hormonal or clinical?
Selectivity Preference or measured distinction in a defined system Which other signals were actually tested?

Ipamorelin versus tesamorelin

The shared growth hormone theme makes these names easy to group together. Their receptor routes differ: ipamorelin is associated with ghrelin-receptor signalling, whereas tesamorelin is a growth hormone-releasing hormone analogue. A shared downstream topic does not establish equivalent activity, evidence or package amounts.

The Ipamorelin versus Tesamorelin comparison explains the catalogue distinction. For a pathway overview, read growth hormone secretagogues explained. Compare the original studies themselves when the question concerns a specific outcome.

Reading a product listing separately from a paper

An original study is evidence about its reported material, model and conditions. It does not authenticate a vial supplied by another organisation. For a listing, check the compound identity, package amount and available exact-lot documentation independently. A nominal vial quantity is not a study outcome or an equivalent amount of a different peptide.

This is also why a product specification and a research profile serve different purposes. The specification describes the offered material. The profile helps you interpret a source. Use both, while keeping any unanswered analytical or lot questions visible.

Questions readers ask

Is ipamorelin supplied growth hormone?

No. A growth hormone secretagogue is a different category from the hormone itself.

Does selectivity prove a universal safety claim?

No. Interpret selectivity within the measurements and conditions of the cited research.

Where are current sizes and prices?

Use the live product listing rather than a research article. This profile does not store prices.

Raun et al.: original ipamorelin pharmacology; Human volunteer pharmacokinetic-pharmacodynamic study.

Read an evidence checklist · Understand a COA · Browse growth hormone research materials.

Read hormone research in context

An observed hormone response is a defined endpoint, rather than proof of every proposed downstream effect. Compare the measured outcomes and check the material identity before joining results from different studies.

Explore this topic further

Ipamorelin in Canada

Reading the evidence

Secretagogue pharmacology and experimental models

The early source concerns pharmacology in laboratory and animal models. Identify the receptor context and the measured hormonal response before interpreting a broader claim. A signalling result is not automatically a personal body-composition or performance outcome.

MaterialWhat exactly was studied?
ModelWhich cells, tissue or population?
EndpointWhat did the source measure?

The Peptide Place Insider

Your first order.
15% better.
Get 15% off
your first order.

Your welcome code, orders and Peptide Points. One free account.

Join Insider emails and create your free Peptide Place account. Unsubscribe anytime. Adults 19+.

Privacy · Offer terms · Already joined? Sign in